Results 261 to 270 of about 146,077 (348)
European Guideline (EuroGuiDerm) on atopic eczema: Living update
The updated guideline includes a new evidence‐based recommendation for the IL‐13 inhibitor lebrikizumab. In addition, the Janus kinase inhibitors baricitinib and abrocitinib, which were initially only approved for adult patients, are now also recommended for children from the age of 2 and adolescents from the age of 12, respectively.
A. Wollenberg+31 more
wiley +1 more source
Use of putative hepatoprotective agents as an adjunct to anti-TB treatment in Europe. [PDF]
Kirakosyan O+37 more
europepmc +1 more source
ABSTRACT Background and Aim Proton pump inhibitors (PPIs) are the drug of choice to prevent upper gastrointestinal (UGI) bleeding in patients receiving dual antiplatelet therapy (DAPT); however, unmet needs remain. Potassium‐competitive acid blockers (P‐CABs) are novel acid‐suppressive drugs that have emerged as potential alternatives. We evaluated the
Minyoul Baik+3 more
wiley +1 more source
MORF: Multi-view oblique random forest for hepatotoxicity prediction. [PDF]
Sui B+6 more
europepmc +1 more source
ABSTRACT The risk of atherosclerotic cardiovascular disease increases with advancing age. Elevated LDL‐cholesterol and non‐HDL‐cholesterol levels remain predictive of incident atherosclerotic cardiovascular events among individuals older than 75 years.
Vera Bittner+8 more
wiley +1 more source
Safety Profile and Hepatotoxicity of Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors: A Disproportionality Analysis Based on FDA Adverse Event Reporting System Database. [PDF]
Yang Y, Tan S, Pu Y, Zhang J.
europepmc +1 more source
Hepatotoxicity of combined therapy with rifampicin and daily prothionamide for leprosy
Baohong Ji+3 more
openalex +1 more source
Abstract Patients with bulky neuroendocrine liver metastases (NELM) undergoing PRRT with [177Lu]Lu‐DOTATATE have a worse survival than patients with limited liver metastases. Previously, the safety and efficacy of additional selective internal radiotherapy (SIRT), using holmium‐166 (166Ho)‐microspheres, directly following PRRT in patients with NELM ...
W. B. Veldhuis+14 more
wiley +1 more source